Contact Us
Drug Search Results
More Filters [+]

Carvedilol

Alternative Names: carvedilol, coreg, dilatrend, coreg cr, sk&f-105517
Latest Update: 2024-12-19
Latest Update Note: Clinical Trial Update

Product Description

Carvedilol is used to treat heart failure (condition in which the heart cannot pump enough blood to all parts of the body) and high blood pressure. It also is used to treat people who have had a heart attack. Carvedilol is often used in combination with other medications. (Sourced from: https://medlineplus.gov/druginfo/meds/a697042.html)

Mechanisms of Action: ADRA1A Antagonist,ADRB Antagonist

Novel Mechanism: No

Modality: Small Molecule

Route of Administration: Oral

FDA Designation: None *

Approval Status: Approved

Approved Countries: Algeria | Argentina | Australia | Austria | Bangladesh | Belgium | Bosnia | Brazil | Bulgaria | Canada | Chile | China | Colombia | Croatia | Cyprus | Czech | Denmark | Dominican Republic | Ecuador | Egypt | Estonia | Finland | France | Germany | Greece | Hong Kong | Hungary | Iceland | India | Indonesia | Ireland | Israel | Italy | Japan | Jordan | Korea | Latvia | Lebanon | Lithuania | Luxembourg | Malaysia | Malta | Mexico | Morocco | Netherlands | New Zealand | Norway | Pakistan | Peru | Philippines | Poland | Portugal | Romania | Russia | Saudi Arabia | Serbia | Singapore | Slovakia | Slovenia | South Africa | Spain | Sri Lanka | Sweden | Switzerland | Taiwan | Thailand | Tunisia | Turkey | Ukraine | United Arab Emirates | United Kingdom | United States | Uruguay | Venezuela | Vietnam

Approved Indications: Heart Block | Heart Failure | Heart Failure, Chronic | Myocardial Infarction | Ventricular Dysfunction | Ventricular Dysfunction, Left | Hypertension

Known Adverse Events: Bradycardia | Heart Failure | Myocardial Infarction | Ventricular Dysfunction | Ventricular Dysfunction, Left | Hypertension | Hypotension | Dizziness | Hyperglycemia | Asthenia | Diarrhea

Company: GlaxoSmithKline
Company Location: BRENTFORD MIDDLESEX X0 TW8 9GS
Company CEO: Emma Walmsley
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Carvedilol

Countries in Clinic: Korea

Active Clinical Trial Count: 1

Highest Development Phases

Phase 3: Tricuspid Valve Insufficiency

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success
PROVE

P3

Active, not recruiting

Tricuspid Valve Insufficiency

2024-12-01

Recent News Events

Date

Type

Title

06/17/2024

News Article

 MyMD Pharmaceuticals Appoints Accomplished Biopharmaceutical Leader and Current Board Member, Mitchell Glass, M.D. as President and Chief Medical Officer

02/15/2024

News Article

 GoodRx Now Offering 30 Common Heart Health Medications for Under $30

10/03/2023

News Article

 LNG Carrier Market Size and Share 2023 Growth Factors, Trends, Key Findings, Future Demands and Forecast Till 2030

09/29/2023

News Article

 Left Ventricular Dysfunction Drug Market 2023 Scope and Growth Prediction Outlook 2029

Did PRYZM just deliver the data you were looking for?
Did you try our Excel download too?

Now that you’ve used PRYZM, we hope you’re able to see for yourself that it was designed and developed by people who actually use this data for a living. By applying next-generation technology for aggregating and curating this info across multiple key sources PRYZM delivering the latest information at your fingertips just the way you need it and with industry leading speed and cost effectiveness.

Our subscribers enjoy unlimited searches and receive this data on their own secure instance so they can overlay any additional internal/proprietary data on top of the search results and blend that data with real-time industry intel from PRYZM. Discover how you can continue to uncover the competitive landscape and drive strategy.

Suggestions